SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-055763
Filing Date
2024-06-25
Accepted
2024-06-25 16:31:45
Documents
4
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0208478-6k_nlspharm.htm 6-K 16974
2 NOTICE OF MEETING AND PROXY CARD FOR THE ORDINARY SHAREHOLDERS' MEETING TO BE HE ea020847801ex99-1_nlspharm.htm EX-99.1 46881
3 GRAPHIC ex99-1_001.jpg GRAPHIC 241469
4 GRAPHIC ex99-1_002.jpg GRAPHIC 439631
  Complete submission text file 0001213900-24-055763.txt   1002987
Mailing Address THE CIRCLE 6 8058 ZURICH V8 CH-6370
Business Address THE CIRCLE 6 8058 ZURICH V8 CH-6370 41-41-618-80-00
NLS Pharmaceutics Ltd. (Filer) CIK: 0001783036 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39957 | Film No.: 241069355
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)